Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if AVXL is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
19 top institutions tracked
Sentiment: unknown
No recent insider trades detected.
Red flags: 2
177 filers reported a long position in AVXL for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| BlackRock, Inc. | $20.9M | 8.1M | +5.9% |
| VANGUARD CAPITAL MANAGEMENT LLC | $10.5M | 4.1M | +4.9% |
| TWO SIGMA INVESTMENTS, LP | $7.9M | 3M | -6.2% |
| GEODE CAPITAL MANAGEMENT, LLC | $6.2M | 2.4M | +10% |
| STATE STREET CORP | $5M | 1.9M | -57.4% |
| FEDERATED HERMES, INC. | $2.8M | 1.1M | +101.4% |
| AQR CAPITAL MANAGEMENT LLC | $2.5M | 963K | +27.2% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.5M | 948.6K | +21.1% |
| Summit Financial, LLC | $2.4M | 909.4K | -3.3% |
| GOLDMAN SACHS GROUP INC | $2.3M | 890.6K | +10.7% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.